REPR is going to continue to be very good to you IMO.....gotta love the business model. Only medicare approved device that's also cheaper and more effective and safer than all of the other devices (read the 10K) -- and patients buy the tubing sets for life that are highly profitable with REPR additionally raising the prices of them.
On top of that they got their long awaited FDA approval for their new needle set which should further accelerate sales and EPS.
So now we have this constantly growing and highly profitable automatic recurring revenue stream PLUS new sales coming on board......so easy even a cave man can get rich off of REPR. :)
Market Data 
Markets 
AI
